申请人:Takeda Chemical Industries, Ltd.
公开号:US04010202A1
公开(公告)日:1977-03-01
Novel aminotetralol compounds of the formula ##STR1## wherein Z.sup.1 and Z.sup.2 are hydrogen or an alkyl group and R.sup.1 is a substituted acyclic hydrocarbon group or a cyclic hydrocarbon group, and their pharmaceutically acceptable salts, have excellent pharmacological activities such as strong bronchodilating activity or .beta.-adrenergic blocking activity. They are useful as medicines, for example, for treatment of asthma or arrhythmia.
新型氨基四醇化合物的化学式为##STR1##,其中Z.sup.1和Z.sup.2是氢或烷基基团,R.sup.1是取代的非环烃基团或环烃基团,以及其药用盐具有出色的药理活性,如强烈的支气管扩张活性或β-肾上腺素受体阻滞活性。它们可用作药物,例如用于治疗哮喘或心律失常。